Shandong Jining NO.1 People's Hospital, Jining, PR China.
Biomed Pharmacother. 2013 Jun;67(5):375-80. doi: 10.1016/j.biopha.2013.03.002. Epub 2013 Mar 24.
MicroRNAs (miRNAs) are a new class of short noncoding RNAs with post-transcriptional regulation and participate in diverse physiological and pathological processes. MiR-22, ubiquitously expressed in various tissues, plays a functional important role in life processes and is recently proved to involve in many cancers. In present study, we had shown that miR-22 was down-regulated much more obviously in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) cell lines as well as in clinical tissues. Cyclin-dependent kinase inhibitor 1A (CDKN1A) was found to be inversely correlated with miR-22 and was identified as a target of miR-22. Overexpression of miR-22 in vitro effectively suppressed CDKN1A expression and inhibited cell proliferation. We conclude that miR-29c may play an important role as a tumor suppressive microRNA in the development and progression of HBV-related HCC by targeting CDKN1A.
微小 RNA(miRNAs)是一类新的短链非编码 RNA,具有转录后调控作用,参与多种生理和病理过程。广泛表达于各种组织中的 miR-22 在生命过程中发挥着重要的功能作用,最近被证明与许多癌症有关。在本研究中,我们发现 miR-22 在乙型肝炎病毒(HBV)相关肝细胞癌(HCC)细胞系以及临床组织中表达下调更为明显。细胞周期蛋白依赖性激酶抑制剂 1A(CDKN1A)与 miR-22 呈负相关,被鉴定为 miR-22 的靶标。体外过表达 miR-22 可有效抑制 CDKN1A 的表达并抑制细胞增殖。我们的结论是,miR-29c 通过靶向 CDKN1A,可能作为一种肿瘤抑制性 microRNA,在 HBV 相关 HCC 的发生和发展中发挥重要作用。